Torben Osterlund

CSO / Directeur Scientifique, Assay quality and validation consultant

Sweden

About

Specialist within in vitro methodologies for biological applications and toxicology, NAM validation ring-trails, reporting and test guideline development, data management and statistics, validation reports, and the OECD test guideline process. All things NAMs, scientific scrutiny, SOPs, test chemicals, regulatory impact, ....... Also: Experienced drug hunter with significant managerial and project experiences. Core competencies includes discovery project ideation/initiation, progression and lead ID, cell efficacy and safety assays, target ID, validation and safety, cell assay development, validation and services, biomarkers efficacy and toxicology. Key specifics: R&D in diabetes and obesity biology, inflammation, cancer biology, lipid metabolism, cell signaling, and more. Peptide and small molecule drug discovery, target ID and validation Functional cell assays and biomarkers In vitro safety assays New Approach Methods in Toxicology, NAM validations and test guidelines Drug target safety assessment GPCR functional selectivity Cell and molecular biology Line and company management Project leadership Supervisor Lab manager Lab safety officer

Experience

  • Chief Scientific Officer / Directeur Scientifique at PEPPER
    Jul 2024 - Present · 2 yrs 1 mo

    Responsible for all scientific aspects of method/assay validation for test guideline approval. Method validation leadership, ring trials, SOP updates, data management and statistical analyzes, writing of validation reports and submission for peer review under OECD. Method evaluation and readiness, recruiting of test labs, onboarding and project leadership. Internal scientific leadership and coaching.

  • Senior Discovery Consultant at Lund Discovery Consulting
    Jun 2022 - Present · 4 yrs 2 mos

    Consulting in all aspects of drug discovery. Supporting startups and SMEs in company and project strategy, including ways forward, IPR and running discovery projects. Also support Taget ID and validation, target safety assessment, cell assays efficacy and safety, chemical strategies and screening cascades, translational/biomarkers and pharmacology, patents/IPR, project leadership, delivery of clinical candidates. Project leadership and due diligence for discovery. Evaluate and challenge project ideas, paths, milestones and more.

  • Chief Scientific Officer at Toxys
    Feb 2021 - Dec 2022 · 1 yr 11 mos

    Heading the R&D efforts to develop new services. Overseeing assay development, refinement and extensions. Supporting marketing and business efforts. Supporting customer projects and interactions. Heading collaborations and in vitro safety developments.

  • Head of Cell Biology at Confo Therapeutics
    Sep 2019 - Apr 2020 · 8 mos

    Cell based potency assays, GPCRs, Cell based phenotypic assays, Department development, Project leadership, Collaborations, Drug discovery lead generation and PoC studies.

  • Project Leader and Expert Scientist at Pelago Bioscience AB
    Nov 2018 - Sep 2019 · 11 mos

    CETSA assay development and implementation, innovation, business support and collaborations, project management.